Patents by Inventor Gilles Desmadryl

Gilles Desmadryl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective histamine H4 receptor antagonists for the treatment of vestibular disorders
    Patent number: 10195195
    Abstract: The invention relates to Histamine H4 receptor antagonists or inhibitors of Histamine H4 receptor gene expression for the treatment and/or the prevention of vestibular disorders.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: February 5, 2019
    Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Gilles Desmadryl, Christian Chabbert
  • SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS
    Publication number: 20170056397
    Abstract: The invention relates to Histamine H4 receptor antagonists or inhibitors of Histamine H4 receptor gene expression for the treatment and/or the prevention of vestibular disorders.
    Type: Application
    Filed: November 8, 2016
    Publication date: March 2, 2017
    Inventors: Gilles Desmadryl, Christian Chabbert
  • Selective Histamine H4 Receptor Antagonists for the Treatment of Vestibular Disorders
    Publication number: 20120039913
    Abstract: The invention relates to Histamine H4 receptor antagonists or inhibitors of Histamine H4 receptor gene expression for the treatment and/or the prevention of vestibular disorders.
    Type: Application
    Filed: December 23, 2009
    Publication date: February 16, 2012
    Applicant: INSERM (institut National de la Sante de la Recher Medicale)
    Inventors: Gilles Desmadryl, Christian Chabbert